A prespecified subgroup analysis of an open-label, multicenter, single-arm, dose-titration study is presented. The efficacy and safety of 20-week treatment with an amlodipine (AML)/olmesartan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results